Literature DB >> 9653035

Expression of an antibody fragment at high levels in the bacterial cytoplasm.

P Martineau1, P Jones, G Winter.   

Abstract

Recombinant antibody fragments expressed in the cytoplasm of cells have considerable practical potential. However in the reducing environment of the cytoplasm, the intradomain disulphide bonds are not formed and the fragments are unstable and expressed in low yields. Here we attempted to overcome these limitations. We first isolated an antibody single chain Fv fragment that binds and activates an inactive mutant beta-galactosidase. We then subjected the gene encoding the scFv fragment to random mutation in vitro by error-prone polymerase chain reaction, and co-expressed the mutant beta-galactosidase and mutant antibody fragments in lac- bacteria. By plating on limiting lactose, we selected for antibody mutants with improved expression, and after four successive rounds of mutation and selection, isolated an antibody fragment that is expressed in the bacterial cytoplasm with yields of 0.5 g/l in a shaker flask (A600 nm of 5.5) and 3.1 g/l (A600 nm=33) in a fermentor. Analysis of the mutant antibody fragments revealed that the disulphide bonds are reduced in the cytoplasm, and that the fragments could be denatured and renatured efficiently under reducing conditions in vitro. This shows that with a suitable method of screening or selection, it is possible to make folded and functional antibody fragments in excellent yield in the cytoplasm. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9653035     DOI: 10.1006/jmbi.1998.1840

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  54 in total

1.  Selection of antibodies for intracellular function using a two-hybrid in vivo system.

Authors:  M Visintin; E Tse; H Axelson; T H Rabbitts; A Cattaneo
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-12       Impact factor: 11.205

2.  Intrabody construction and expression III: engineering hyperstable V(H) domains.

Authors:  P Wirtz; B Steipe
Journal:  Protein Sci       Date:  1999-11       Impact factor: 6.725

Review 3.  Antibody-based resistance to plant pathogens.

Authors:  S Schillberg; S Zimmermann; M Y Zhang; R Fischer
Journal:  Transgenic Res       Date:  2001       Impact factor: 2.788

4.  Role of native-state topology in the stabilization of intracellular antibodies.

Authors:  G Settanni; A Cattaneo; A Maritan
Journal:  Biophys J       Date:  2001-11       Impact factor: 4.033

5.  De novo production of diverse intracellular antibody libraries.

Authors:  Tomoyuki Tanaka; Grace T Y Chung; Alan Forster; M Natividad Lobato; Terence H Rabbitts
Journal:  Nucleic Acids Res       Date:  2003-03-01       Impact factor: 16.971

Review 6.  Engineered antibody therapies to counteract mutant huntingtin and related toxic intracellular proteins.

Authors:  David C Butler; Julie A McLear; Anne Messer
Journal:  Prog Neurobiol       Date:  2011-11-18       Impact factor: 11.685

7.  A rapid protein folding assay for the bacterial periplasm.

Authors:  Thomas J Mansell; Stephen W Linderman; Adam C Fisher; Matthew P DeLisa
Journal:  Protein Sci       Date:  2010-05       Impact factor: 6.725

Review 8.  Targeting antibodies to the cytoplasm.

Authors:  Andrea L J Marschall; André Frenzel; Thomas Schirrmann; Manuela Schüngel; Stefan Dübel
Journal:  MAbs       Date:  2011-01-01       Impact factor: 5.857

9.  Protein quantification from complex protein mixtures using a proteomics methodology with single-cell resolution.

Authors:  H T Zhang; J E Kacharmina; K Miyashiro; M I Greene; J Eberwine
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

10.  Efficient isolation of soluble intracellular single-chain antibodies using the twin-arginine translocation machinery.

Authors:  Adam C Fisher; Matthew P DeLisa
Journal:  J Mol Biol       Date:  2008-11-01       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.